{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:55:48Z","timestamp":1779335748077,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012866","name":"Cumming School of Medicine, University of Calgary","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012866","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.bioorg.2019.103187","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T11:12:22Z","timestamp":1565176342000},"page":"103187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Discovery of Michael acceptor containing 1,4-dihydropyridines as first covalent inhibitors of L-\/T-type calcium channels"],"prefix":"10.1016","volume":"91","author":[{"given":"Hande","family":"Ayg\u00fcn Cevher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria A.","family":"Gandini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozan","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eder","family":"Gambeta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang Xiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"\u00c7elebier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Nawaz","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald W.","family":"Zamponi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Wolber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyase G\u00f6zde","family":"G\u00fcnd\u00fcz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.103187_b0005","first-page":"821","article-title":"The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential","volume":"67","author":"Zamponi","year":"2015","journal-title":"Pharmacol. Rev. Pharmacol Rev."},{"key":"10.1016\/j.bioorg.2019.103187_b0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2015.5","article-title":"Targeting voltage-gated calcium channels in neurological and psychiatric diseases","volume":"15","author":"Zamponi","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2019.103187_b0015","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/jhet.2837","article-title":"Cardiovascular calcium channel blockers: historical overview, development and new approaches in design","volume":"54","author":"Drapak","year":"2017","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2019.103187_b0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.biocel.2019.01.008","article-title":"T-type calcium channels: from molecule to therapeutic opportunities","volume":"108","author":"Weiss","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bioorg.2019.103187_b0025","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0026-895X(24)12129-3","article-title":"Synthesis and evaluation of a new class of nifedipine analogs with T-type calcium channel blocking activity","volume":"61","author":"Kumar","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bioorg.2019.103187_b0030","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00424-013-1376-z","article-title":"Synthesis and evaluation of 1,4-dihydropyridine derivatives with calcium channel blocking activity","volume":"466","author":"Bladen","year":"2014","journal-title":"Pfl\u00fcgers Arch. - Eur. J. Physiol."},{"key":"10.1016\/j.bioorg.2019.103187_b0035","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00424-014-1566-3","article-title":"1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain","volume":"467","author":"Bladen","year":"2015","journal-title":"Pfl\u00fcgers Arch. - Eur. J. Physiol."},{"key":"10.1016\/j.bioorg.2019.103187_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11010028","article-title":"A new generation of dihydropyridine calcium channel blockers: photostabilization of liquid formulations using nonionic surfactants","author":"Ioele","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2019.103187_b0045","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s00424-015-1725-1","article-title":"Analgesic effect of a broad-spectrum dihydropyridine inhibitor of voltage-gated calcium channels","volume":"467","author":"Gadotti","year":"2015","journal-title":"Pfl\u00fcgers Arch. - Eur. J. Physiol."},{"key":"10.1016\/j.bioorg.2019.103187_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2018.05.032","article-title":"Binding mechanism investigations guiding the synthesis of novel condensed 1,4-dihydropyridine derivatives with L-\/T-type calcium channel blocking activity","volume":"155","author":"Schaller","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103187_b0055","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/minf.201000019","article-title":"Bioisosteric replacement and scaffold hopping in lead generation and optimization","volume":"29","author":"Langdon","year":"2010","journal-title":"Mol. Inform."},{"key":"10.1016\/j.bioorg.2019.103187_b0060","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1021\/cr950066q","article-title":"Bioisosterism: a rational approach in drug design","volume":"96","author":"Patani","year":"1996","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2019.103187_b0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd3410","article-title":"The resurgence of covalent drugs","volume":"10","author":"Singh","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2019.103187_b0070","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.drudis.2015.05.005","article-title":"Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies","volume":"20","author":"Bauer","year":"2015","journal-title":"Drug Discov. Today."},{"key":"10.1016\/j.bioorg.2019.103187_b0075","first-page":"1330","article-title":"Reversible Michael additions: covalent inhibitors and prodrugs","volume":"12","author":"Johansson","year":"2012","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103187_b0080","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3390\/80400381","article-title":"Synthesis and aromatization of Hantzsch 1,4-dihydropyridines under microwave irradiation. An overview","volume":"8","author":"Vanden Eynde","year":"2003","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2019.103187_b0085","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ddr.21024","article-title":"Synthesis and myorelaxant activity of fused 1,4-dihydropyridines on isolated rabbit gastric fundus","volume":"73","author":"\u015eafak","year":"2012","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2019.103187_b0090","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3906\/kim-1412-72","article-title":"Microwave-assisted synthesis of condensed 1,4-dihydropyridines as potential calcium channel modulators","volume":"39","author":"\u00d6zer","year":"2015","journal-title":"TURKISH J. Chem."},{"key":"10.1016\/j.bioorg.2019.103187_b0095","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.3390\/ijms20102513","article-title":"Direct enantiomeric resolution of seventeen racemic 1,4-dihydropyridine-based hexahydroquinoline derivatives by HPLC","volume":"20","author":"Sun","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2019.103187_b0100","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1039\/b510276f","article-title":"Ammonium carbamate; mild, selective and efficient ammonia source for preparation of \u03b2-amino-\u03b1, \u03b2-unsaturated esters at room temperature","volume":"7","author":"Litvi\u0107","year":"2005","journal-title":"Green Chem."},{"key":"10.1016\/j.bioorg.2019.103187_b0105","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1016\/j.tetlet.2012.04.088","article-title":"Synthesis of 2,3-diaryl-5H-imidazo[2,1-a]isoindol-5-ones via the one-pot reaction of 1,2-diketones, 2-formylbenzoic acids, and ammonium acetate","volume":"53","author":"Hosseini-Zare","year":"2012","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2019.103187_b0110","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/anie.199515551","article-title":"Patterns in hydrogen bonding: functionality and graph set analysis in crystals","volume":"34","author":"Bernstein","year":"1995","journal-title":"Angew. Chemie Int. Ed. English"},{"key":"10.1016\/j.bioorg.2019.103187_b0115","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1021\/cr010182v","article-title":"Irreversible inhibitors of serine, cysteine, and threonine proteases","volume":"102","author":"Powers","year":"2002","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2019.103187_b0120","series-title":"Virtual Screen. Drug Discov","first-page":"379","article-title":"Protein-Ligand Docking and Virtual Screening with GOLD","author":"Cole","year":"2005"},{"key":"10.1016\/j.bioorg.2019.103187_b0125","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/ci049885e","article-title":"LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters","volume":"45","author":"Wolber","year":"2005","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2019.103187_b0130","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.1021\/acs.jpcb.7b04198","article-title":"Do halogen-hydrogen bond donor interactions dominate the favorable contribution of halogens to ligand-protein binding?","volume":"121","author":"Lin","year":"2017","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bioorg.2019.103187_b0135","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1021\/tx800492x","article-title":"Kinetic glutathione chemoassay to quantify thiol reactivity of organic electrophiles application to \u03b1, \u03b2-unsaturated ketones, acrylates, and propiolates","volume":"22","author":"B\u00f6hme","year":"2009","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bioorg.2019.103187_b0140","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/cmdc.201000020","article-title":"Mechanistic study of the reaction of thiol-containing enzymes with \u03b1, \u03b2-unsaturated carbonyl substrates by computation and chemoassays","volume":"5","author":"Paasche","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2019.103187_b0145","first-page":"1133","article-title":"Quantitative structure-property relationships for the chemical reactivity of acrylates and methacrylates","volume":"18","author":"Freidig","year":"1999","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.bioorg.2019.103187_b0150","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S0108767307043930","article-title":"A short history of SHELX","volume":"64","author":"Sheldrick","year":"2008","journal-title":"Acta Crystallogr. Sect. A Found. Crystallogr."},{"key":"10.1016\/j.bioorg.2019.103187_b0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. Sect. C Struct. Chem."},{"key":"10.1016\/j.bioorg.2019.103187_b0160","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1107\/S0021889812029111","article-title":"IUCr, WinGX and ORTEP for Windows: an update","volume":"45","author":"Farrugia","year":"2012","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.bioorg.2019.103187_b0165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1107\/S0021889802022112","article-title":"IUCr, Single-crystal structure validation with the program PLATON","volume":"36","author":"Spek","year":"2003","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.bioorg.2019.103187_b0170","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00424-013-1259-3","article-title":"Surface expression and function of Cav3.2 T-type calcium channels are controlled by asparagine-linked glycosylation","volume":"465","author":"Weiss","year":"2013","journal-title":"Pfl\u00fcgers Arch. - Eur J. Physiol."},{"key":"10.1016\/j.bioorg.2019.103187_b0175","unstructured":"Chemical Computing Group Inc., Molecular Operating Environment (MOE), (2018) 1010 Sherbooke St. West, Suite #910."},{"key":"10.1016\/j.bioorg.2019.103187_b0180","first-page":"1000","article-title":"Comparison of automatic three-dimensional model builders using 639 X-ray structures","volume":"34","author":"Sadowski","year":"1994","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2019.103187_b0185","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1074\/jbc.271.10.5293","article-title":"Molecular determinants of high affinity dihydropyridine binding in L-type calcium channels","volume":"271","author":"Peterson","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2019.103187_b0190","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1002\/j.1460-2075.1996.tb00592.x","article-title":"The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines","volume":"15","author":"Schuster","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.bioorg.2019.103187_b0195","doi-asserted-by":"crossref","first-page":"18752","DOI":"10.1074\/jbc.272.30.18752","article-title":"Analysis of the dihydropyridine receptor site of L-type calcium channels by alanine-scanning mutagenesis","volume":"272","author":"Peterson","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2019.103187_b0200","doi-asserted-by":"crossref","first-page":"12730","DOI":"10.1074\/jbc.M010164200","article-title":"Mechanism of dihydropyridine interaction with critical binding residues of L-type Ca2+ channel alpha 1 subunits","volume":"276","author":"Wappl","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2019.103187_b0205","doi-asserted-by":"crossref","unstructured":"A. Senatore, A. Boone, S. Lam, T.F. Dawson, B. Zhorov, Jd. Spafford, Mapping of dihydropyridine binding residues in a less sensitive invertebrate L-type calcium channel (LCav1), Channels. 5 (2011) 173\u2013187. doi:10.4161\/chan.5.2.15141.","DOI":"10.4161\/chan.5.2.15141"},{"key":"10.1016\/j.bioorg.2019.103187_b0210","doi-asserted-by":"crossref","first-page":"41504","DOI":"10.1074\/jbc.M007165200","article-title":"Serine residue in the IIIS5-S6 linker of the L-type Ca2+ channel alpha 1C subunit is the critical determinant of the action of dihydropyridine Ca2+ channel agonists","volume":"275","author":"Yamaguchi","year":"2000","journal-title":"J. Biol. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819309290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819309290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:57:43Z","timestamp":1758614263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819309290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":42,"alternative-id":["S0045206819309290"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103187","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of Michael acceptor containing 1,4-dihydropyridines as first covalent inhibitors of L-\/T-type calcium channels","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103187"}}